Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Antimicrobial Consumer Product Resistance Concerns Voiced By AMA

This article was originally published in The Tan Sheet

Executive Summary

The use of consumer products containing antimicrobial agents could be creating a favorable environment for organisms resistant to antibiotics, according to a report approved by the American Medical Association at its annual meeting in Chicago June 11-15.

You may also be interested in...



Ban On Non-Medical Uses Of Triclosan Products Sought In Citizen Petition

Bacterial resistance that may result from use of triclosan should cause FDA to "immediately ban all non-medical uses" of the antibacterial agent, a coalition of public interest groups maintains in a citizen petition filed with the agency

Ban On Non-Medical Uses Of Triclosan Products Sought In Citizen Petition

Bacterial resistance that may result from use of triclosan should cause FDA to "immediately ban all non-medical uses" of the antibacterial agent, a coalition of public interest groups maintains in a citizen petition filed with the agency

Ban On Non-Medical Uses Of Triclosan Products Sought In Citizen Petition

Bacterial resistance that may result from use of triclosan should cause FDA to "immediately ban all non-medical uses" of the antibacterial agent, a coalition of public interest groups maintains in a citizen petition filed with the agency

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091319

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel